BioCatalyst

AAA617, ARPI: Abiraterone, ARPI: Enzalutamide — catalyst calendar

1 verified catalyst event(s) referencing AAA617, ARPI: Abiraterone, ARPI: Enzalutamide, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-15
in 4mo
ESTIMATED
 READOUT
An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combin
Phase 2 · Metastatic Castration Resistant Prostate Cancer (mCRPC)
 NVS NOVARTIS AG AAA617, ARPI: Abiraterone, ARPI: Enzalut ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.